Unknown OBSERVATIONAL NCT04768413

Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis

Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis Highly Vulnerable to the 2019 Novel Coronavirus Disease

Sponsor: Biomab I.P.S. Centro de Atencion Integral en Artritis Reumatoide

Conditions Rheumatoid Arthritis

Interventions Care modalities. Quantitative and qualitative approaches to analysis Teleconsultation either by phone or by computer consultation. Quantitative and qualitative approaches to analysis

Updated 4 times since 2021 Last updated: Feb 22, 2021 Started: Jun 1, 2020 Primary completion: Apr 30, 2021 Completion: Jun 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Rheumatoid Arthritis and is currently ongoing. Biomab I.P.S. Centro de Atencion Integral en Artritis Reumatoide leads this study, which shows 4 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Mar 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Mar 2021 — Mar 2023 [monthly]

Recruiting

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biomab I.P.S. Centro de Atencion Integral en Artritis Reumatoide
Fundación Universitaria de Ciencias de la Salud

Data source: Fundación Universitaria de Ciencias de la Salud

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bogota, Colombia